 CARLSBAD, Calif. , Nov. 10, 2022 PRNewswire -- Tyra Biosciences, Inc. Nasdaq: TYRA, a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that the Company will be presenting and hosting one-on-one meetings at the following conferences in November: H.C. 